VEEV - Veeva Systems Inc.
NEXT EARNINGS:
Mar 4, 2026
(in 7 days)
EPS Est: $1.92
|
Rev Est: $810.9M
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$297.93
DETAILS
HIGH:
$355.00
LOW:
$205.00
MEDIAN:
$300.00
CONSENSUS:
$297.93
UPSIDE:
69.48%
Market Cap:
28.90B
Volume:
1,708,366
Avg Volume:
1,988,318
52 Week Range:
168.14-310.5
Sector:
Healthcare
Industry:
Medical - Healthcare Information Services
Beta:
1.08
Last Dividend:
$N/A
Exchange:
NYSE
Country:
US
Employees:
7,291
IPO Date:
2013-10-16
EPS (TTM):
4.41
P/E Ratio:
52.87
Revenue (TTM):
2.75B
Total Assets:
7.34B
Total Debt:
75.78M
Cash & Equiv:
1.12B
Rev Growth (5Y):
20.0%
EPS Growth (5Y):
16.7%
FCF Growth (5Y):
19.7%
ROCE:
11.6%
Debt/Equity:
0.01
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-11-20 | $2.04 | $1.95 | +4.6% | $811.2M | $792.8M | +2.3% |
| 2025-08-27 | $1.99 | $1.90 | +4.7% | $789.1M | $768.4M | +2.7% |
| 2025-05-28 | $1.97 | $1.74 | +13.2% | $759.0M | $728.4M | +4.2% |
| 2025-03-05 | $1.74 | $1.60 | +8.7% | $720.9M | $699.2M | +3.1% |
| 2024-12-05 | $1.75 | $1.58 | +10.8% | $699.2M | $684.4M | +2.2% |
| 2024-08-28 | $1.62 | $1.53 | +5.9% | $676.2M | $667.8M | +1.3% |
| 2024-05-30 | $1.50 | $1.42 | +5.6% | $650.3M | $642.1M | +1.3% |
| 2024-02-29 | $1.38 | $1.30 | +6.2% | $630.6M | $621.1M | +1.5% |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.75B | 2.36B | 2.16B | 1.85B | 1.47B | 1.10B | 862.21M | 690.56M | 544.04M | 409.22M | 313.22M | 210.15M |
| Net Income | 714.14M | 525.71M | 487.71M | 427.39M | 380.00M | 301.12M | 229.83M | 151.18M | 77.57M | 54.46M | 40.38M | 23.61M |
| EPS | 4.41 | 3.27 | 3.14 | 2.79 | 2.52 | 2.04 | 1.59 | 1.08 | 0.51 | 0.41 | 0.31 | 0.20 |
| Total Assets | 7.34B | 5.91B | 4.80B | 3.82B | 3.05B | 2.27B | 1.65B | 1.23B | 917.70M | 705.80M | 544.89M | 370.31M |
| Total Debt | 75.78M | 55.77M | 60.98M | 54.59M | 63.12M | 54.83M | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash & Equivalents | 1.12B | 703.49M | 886.47M | 1.14B | 730.50M | 476.73M | 550.97M | 320.18M | 217.61M | 132.18M | 129.25M | 262.51M |
| Operating Cash Flow | 1.09B | 911.34M | 780.47M | 764.46M | 551.25M | 437.38M | 310.83M | 233.44M | 144.01M | 80.15M | 67.57M | 41.75M |
| Free Cash Flow | 1.07B | 885.14M | 766.96M | 750.25M | 542.56M | 434.26M | 302.39M | 223.81M | 137.09M | 59.00M | 41.04M | 39.89M |
| FCF per Share | 6.61 | 5.51 | 4.94 | 4.90 | 3.60 | 2.94 | 2.10 | 1.60 | 0.94 | 0.45 | 0.32 | 0.39 |
| Book Value | 5.83B | 4.64B | 3.72B | 2.91B | 2.27B | 1.67B | 1.24B | 906.24M | 652.98M | 505.25M | 406.83M | 280.10M |
| Cash & ST Investments | 5.15B | 4.03B | 3.10B | 2.38B | 1.66B | 1.09B | 1.09B | 761.96M | 518.87M | 346.20M | 397.87M | 288.13M |
| ROC Equity | 0.12 | 0.11 | 0.13 | 0.15 | 0.17 | 0.18 | 0.19 | 0.17 | 0.12 | 0.11 | 0.10 | 0.08 |